椎基底动脉系统扩张性动脉瘤:预测不良结局的临床与影像学因素
该研究回顾了3个脑血管中心2000年1月1日至2015年1月1日诊断的50例未破裂梭形基底动脉扩张性动脉瘤患者,平均临床随访50.1个月,末次随访时42%(n=21)动脉瘤进展、44%(n=22)改良Rankin量表评分恶化,多因素分析显示就诊时后颅窝受压症状是临床恶化的唯一显著预测因素(p=0.01)。
要点
- 梭形扩张性椎基底动脉瘤预后差,约半数患者在5年内恶化或动脉瘤进展。
- 单因素分析中性别、影像学脑干受压、临床后颅窝受压、动脉瘤生长及手术治疗与恶化显著相关。
- 多因素分析仅就诊时后颅窝受压症状是临床恶化的显著预测因素(p=0.01)。
核心结论
- 梭形扩张性椎基底动脉瘤预后差,约半数患者在5年内恶化或动脉瘤进展。
- 尽管风险高,在选定患者中,精心选择时机(神经功能下降前)的干预可能有益。
研究设计与样本
- 回顾性分析3个大型脑血管中心多个前瞻性维护的单提供者数据库。
- 纳入2000年1月1日至2015年1月1日诊断的未破裂梭形基底动脉扩张性动脉瘤患者50例(男33例,女17例)。
- 平均临床随访50.1个月,平均影像学随访32.4个月。
主要发现
- 末次随访时42%(n=21)动脉瘤进展,44%(n=22)患者改良Rankin量表评分恶化。
- 单因素分析显示性别(p=0.007)、影像学脑干受压(p=0.03)、临床后颅窝受压(p<0.001)、后续影像学动脉瘤生长(p=0.001)及手术治疗(p=0.006)在恶化组与未恶化组间差异有统计学意义。
- 二元逻辑回归显示,仅就诊时后颅窝受压症状是临床恶化的显著预测因素(p=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Fusiform dolichoectatic vertebrobasilar aneurysms are rare, challenging lesions. The natural history of these lesions and medium- and long-term patient outcomes are poorly understood. The authors sought to evaluate patient prognosis after diagnosis of fusiform dolichoectatic vertebrobasilar aneurysms and to identify clinical and radiographic predictors of neurological deterioration. METHODS The authors reviewed multiple, prospectively maintained, single-provider databases at 3 large-volume cerebrovascular centers to obtain data on patients with unruptured, fusiform, basilar artery dolichoectatic aneurysms diagnosed between January 1, 2000, and January 1, 2015. RESULTS A total of 50 patients (33 men, 17 women) were identified; mean clinical follow-up was 50.1 months and mean radiographic follow-up was 32.4 months. At last follow-up, 42% (n = 21) of aneurysms had progressed and 44% (n = 22) of patients had deterioration of their modified Rankin Scale scores. When patients were dichotomized into 2 groups- those who worsened and those who did not-univariate analysis showed 5 variables to be statistically significantly different: sex (p = 0.007), radiographic brainstem compression (p = 0.03), clinical posterior fossa compression (p < 0.001), aneurysmal growth on subsequent imaging (p = 0.001), and surgical therapy (p = 0.006). A binary logistic regression was then created to evaluate these variables. The only variable found to be a statistically significant predictor of clinical worsening was clinical symptoms of posterior fossa compression at presentation (p = 0.01). CONCLUSIONS Fusiform dolichoectatic vertebrobasilar aneurysms carry a poor prognosis, with approximately one-half of the patients deteriorating or experiencing progression of their aneurysm within 5 years. Despite being high risk, intervention-when carefully timed (before neurological decline)-may be beneficial in select patients.
引用
- Xu DS, Levitt MR, Kalani MYS, et al. Dolichoectatic aneurysms of the vertebrobasilar system: clinical and radiographic factors that predict poor outcomes. J Neurosurg. 2017. PMID: 28387624. doi:10.3171/2016.10.JNS161041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。